Navigation Links
Reportlinker Adds Biomarkers - technologies, markets and companies
Date:9/7/2010

rkers 209

VEGF signalling inhibitors as biomarkers 210

Biomarkers of prognosis in cancer treatment 210

Biomarkers of drug resistance in cancer 210

A systems approach to biomarkers of innate drug resistance 211

Epithelial membrane protein-1 as a biomarker of gefitinib resistance 211

Methylation biomarkers of drug resistance in cancer 211

Biomarkers of radiation exposure 212

Role of biomarkers in drug development in oncology 212

Molecular imaging of tumor as a guide to drug development 213

Use of PET to assess response to anticancer drugs 213

Use of MRI to assess response to anticancer drugs 214

Biomarkers in plucked hair for assessing cancer therapy 214

Molecular targets of anticancer drugs as biomarkers 214

Safety biomarkers in oncology studies 215

Role of biomarkers in phase I clinical trials of anticancer drugs 215

Biomarkers according to location/type of cancer 215

Bladder cancer biomarkers 215

Detection of FGFR3 mutations in urine for diagnosis of bladder cancer 216

NMP22 BladderChek 216

Urinary telomerase as biomarker for detection of bladder cancer 216

Concluding remarks abut biomarkers of urinary cancer 216

Brain cancer biomarkers 217

Biomarkers to predict response to EGFR inhibitors 217

CD133 as biomarker of resistance to radiotherapy 218

Circulating microvesicles as biomarkers 218

CSF protein profiling 218

CSF attractin as a biomarker of malignant astrocytoma 218

Methylation profiling of brain tumors 219

Metabolite biomarkers of brain tumors 220

miRNAs as biomarkers of brain tumors 220

MRI biomarker for response of brain tumor to therapy 220

Multigene predictor of outcome in GBM 221

Neuroimaging biomarkers combined with DNA microarray analysis 221

Receptor protein tyrosine phosphatase ? as biomarker of gliomas 221

Se
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related biology news :

1. Reportlinker Adds Carbon Dioxide Monitors Report
2. Reportlinker Adds World Dynamic Signature Verification Market Report
3. Reportlinker Adds Proteomics: Technologies and Global Markets Report
4. Biomarkers for identifying infant infections
5. Compendium of pancreatic cancer biomarkers established as strategic approach to early-detection
6. Prostate Cancer Translational Research in Europe meeting: Search for biomarkers continues
7. Assessing lead time of selected ovarian cancer biomarkers
8. Pacific Biometrics, Inc. Stockholders Approve Company Name Change to Pacific Biomarkers, Inc.
9. Scientists use nanosensors for first time to measure cancer biomarkers in blood
10. Pacific Biomarkers, Inc. Schedules Second Quarter Conference Call for Friday, February 12, 2010
11. New biomarkers for predicting the spread of colon cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/10/2015)... and TELTOW, Germany , August 10, ... (SMI), a world leader in Eye Tracking Technology for ... its OEM Eye Tracking Platform for integration into all ... contains reference designs for seamless integration of eye tracking ... reality HMDs and augmented reality smart glasses. Omnivision,s leading ...
(Date:8/5/2015)... -- According to a new market research ... Vertical (BFSI, Airport, IT & Telecom, Utilities, Education, Defense ... 2020", published by MarketsandMarkets, defines and segments the Physical ... The global PIAM Market is estimated to grow from ... at a CAGR of 14.9 % from 2014 to ...
(Date:8/3/2015)... Synaptics, Inc. (Nasdaq: SYNA ), the ... members of the executive management team will present to ... Leadership Forum on Tuesday, August 11, 2015 at 1:00 ... the Sonnenalp Resort in Vail, CO. ... information. An audio webcast of the event will be ...
Breaking Biology News(10 mins):SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4
... of new coal-fired power plants in the United States ... due to the high cost of the requirement ... of carbon dioxide, an important greenhouse gas. But an ... construction moving again, allowing the nation to fend off ...
... by researchers at UC Davis Medical Center suggests that ... be a result of their brains not telling their ... blood oxygen levels are more common than we thought ... Masud Seyal, a professor of neurology at UC Davis ...
... , Thanks to our ability to learn and to remember, we ... of. However, we are only just beginning to get the gist ... or forgets something. What we do know is that changes in ... these structural changes account for that well-known phenomenon that it is ...
Cached Biology News:MIT: A quicker, easier way to make coal cleaner 2MIT: A quicker, easier way to make coal cleaner 3Drops in blood oxygen levels may be key to sudden death in some epilepsy patients 2Drops in blood oxygen levels may be key to sudden death in some epilepsy patients 3Forgotten but not gone -- how the brain takes care of things 2Forgotten but not gone -- how the brain takes care of things 3
(Date:9/2/2015)... Wellinton, Florida (PRWEB) , ... September 02, 2015 ... ... has been treated and managed with the use of special anti-vascular endothelial growth ... occurs in many more patients, currently does not have a scientific protocol for ...
(Date:9/2/2015)... 2015 Biovista Inc. is glad ... 2015 BeHEARD science challenge, a global competition hosted by ... access to the latest life science innovations and technologies. ... pathway analytics capability to support Steven Laffoon ... study of Niemann-Pick Disease Type A (NPA), a rare ...
(Date:9/2/2015)... Aytu BioScience, Inc. (OTCQB: AYTU), a specialty ... related conditions, announced today that it has closed the ... financing, raising a total of $5.175 million, which includes ... Josh Disbrow , Chief Executive Officer ... intended to be used to conduct clinical studies for ...
(Date:9/2/2015)... CHARLOTTESVILLE, Virginia , September 2, 2015 /PRNewswire/ ... Sponsoring der Gewinner des Wettbewerbs BeHEARD von 2015 ... einen internationalen vom Rare Genomics Institute. ... Wirksamkeit von Medikamenten für die Behandlung anderer Krankheiten ... wurde, Steven Laffoon und sein Team ...
Breaking Biology Technology:StemCell GeneticMed Announces That It Has Started Stem Cell Treatments for Age Related Dry Macular Degeneration (AMG) 2Biovista Sponsors Wylder Nation Foundation's Research on Acid Sphingomyelinase Deficiency 2Aytu BioScience Completes $5.175 Million Private Placement 2Aytu BioScience Completes $5.175 Million Private Placement 3Biovista sponsert die Forschung von Wylder Nation Foundation zum Thema Mangel an saurer Sphingomyelinase 2
... Pharmaceuticals, Inc. (NYSE Amex: ANX ) today ... ended December 31, 2008."2008 was a transition year for ... focused on lower-risk reformulations of previously-approved drugs. We achieved ... the difficult economic environment, we were unable to attract ...
... Insmed Inc. (Nasdaq: INSM ), a developer of ... March 23, 2009, NASDAQ issued a notice further extending the ... price and those rules requiring a minimum market value of ... effect through Friday, July 17, 2009, and the original rules ...
... /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ... patient enrolment in its U.K. clinical trial to ... REOLYSIN(R) in combination with gemcitabine (Gemzar(R)) in patients ... neck. The principal investigators are Dr. Johann de ...
Cached Biology Technology:ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results 2ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results 3ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results 4ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results 5ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results 6ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results 7Insmed Announces That NASDAQ Further Extends Temporary Suspension of Minimum Bid Closing Price Rule 2Oncolytics Biotech(R) Inc. Completes Enrolment in Combination REOLYSIN(R)/Gemcitabine Trial 2Oncolytics Biotech(R) Inc. Completes Enrolment in Combination REOLYSIN(R)/Gemcitabine Trial 3
... The wide mini ReadySub-Cell GT cell and ... horizontal gel electrophoresis of nucleic acids in agarose ... buffer tank, lid with cables and electrodes, and ... and 220-240 V, provides output of 10-300 V, ...
... and you reduce the chance of error. ... 8000. Developed using Beckman Coulters extensive experience ... electrophoresis technology, the CEQ 8000 is a ... automatically fills the capillary array with a ...
... 2000 Capillary Electrophoresis System uses revolutionary ... electrophoresis (SPE), urine protein electrophoresis and ... accurate analysis. The system is truly ... and no staining to process patient ...
The filter 695RDF55 Reflect 635 for the Molecular Imager FX is a band pass filter for Cy5 and Alexa Fluor 635 dyes....
Biology Products: